• Most Popular
  • Most Shared

Lonza extends supply deal with Bristol-Myers

Mon Mar 12, 2007 2:24am EDT

Stocks

   

ZURICH, March 12 (Reuters) - Swiss pharmaceuticals industry supplier Lonza (LONN.VX) said on Monday it had extended a supply agreement for the active ingredient of Bristol-Myers Squibb's (BMY.N) rheumatoid arthritis drug Orencia until the end of 2013.

Orencia, given by intravenous infusion, was launched in the United States last year.

Lonza did not disclose financial details of the agreement.

((Reporting by Sam Cage,

Email: zurich.newsroom@reuters.com

Reuters Messaging:

sam.cage.reuters.com@reuters.net

Telephone: +41 (0) 44 631 7457)) Keywords: LONZA BRISTOLMYERS/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nZAT006227


More from Reuters

Photo

Home prices flat after five months of gains

NEW YORK (Reuters) - U.S. home prices were unchanged in October, according to the widely watched Standard & Poor's/Case-Shiller indexes released on Tuesday, indicating stabilization in the hard-hit housing sector though the figures dashed hopes for a sixth straight monthly increase.

» More Top News
An employee swipes a customer's credit card through the card reader at a restaurant in Tokyo February 19, 2005.REUTERS/Issei Kato

Taking a swipe at credit cards

New legislation meant to protect consumers could be a "game changer" for the industry -- and not in a good way.  Full Article 

Economy
A traveller lifts her arms as she stands in the new security scan at Schiphol airport, Netherlands, May 15, 2007.REUTERS/Jerry Lampen

Are you ok getting "naked"?

Full-body scanners can detect weapons under clothing but also expose passengers to operators. Should security trump privacy?  Full Article | Video 

U.S.